What is the difference between Progesterone (P4) 160MG Sustained Release (SR) and micronized Progesterone (P4) 200mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differences Between Progesterone 160mg SR and Micronized Progesterone 200mg

Progesterone 160mg SR (sustained release) and micronized progesterone 200mg differ primarily in their release mechanism, with the SR formulation providing more consistent hormone levels throughout the day compared to standard micronized progesterone.

Key Differences

Release Mechanism

  • Progesterone 160mg SR: Provides gradual, sustained release of progesterone over an extended period
  • Micronized Progesterone 200mg: Delivers a more immediate release with potential fluctuations in blood levels

Pharmacokinetics

  • SR formulation:
    • More stable serum levels throughout the day
    • Potentially fewer peak-related side effects
    • May require less frequent dosing
  • Micronized formulation:
    • More rapid absorption
    • Higher peak concentrations
    • May require more frequent dosing to maintain therapeutic levels

Clinical Applications

Both formulations are used in similar clinical scenarios, but with some important considerations:

  1. Hormone Replacement Therapy (HRT):

    • Micronized progesterone 200mg is well-established for endometrial protection in HRT regimens 1
    • The 200mg dose is specifically recommended in guidelines for opposing estrogen effects 1
  2. Preterm Birth Prevention:

    • Micronized progesterone 200mg has been studied extensively for preventing preterm birth in women with short cervix 1
    • The 200mg formulation is specifically mentioned in guidelines for this indication
  3. Endometrial Protection:

    • Both formulations provide endometrial protection, but micronized progesterone 200mg has more extensive clinical evidence 1

Safety Profile

Both formulations share the favorable safety profile of natural progesterone compared to synthetic progestins:

  • Lower cardiovascular risk 1
  • Neutral or beneficial effect on blood pressure 1
  • Better safety profile for thrombotic risk 1, 2
  • Fewer metabolic side effects than synthetic progestins 3, 2

Clinical Considerations

When to Consider SR Formulation

  • Patients experiencing side effects with standard micronized progesterone
  • Those who might benefit from more stable hormone levels
  • Patients who prefer once-daily dosing

When to Consider Micronized Progesterone 200mg

  • When following evidence-based guidelines that specifically recommend this formulation
  • For preterm birth prevention in women with short cervix 1
  • For standard HRT regimens with established protocols 1

Common Pitfalls

  1. Assuming equivalence: The formulations are not directly interchangeable despite similar doses
  2. Overlooking bioavailability differences: SR formulation may have different overall bioavailability
  3. Ignoring evidence base: Most clinical guidelines specifically reference the 200mg micronized formulation, particularly for preterm birth prevention and HRT
  4. Disregarding timing of administration: Micronized progesterone is often recommended at bedtime to minimize side effects like drowsiness 4

Summary

While both formulations contain natural progesterone with similar therapeutic effects, the SR formulation offers more consistent blood levels throughout the day. However, the micronized 200mg formulation has more extensive clinical evidence supporting its use in specific indications like HRT and preterm birth prevention. The choice between formulations should consider the specific indication, patient tolerance, and adherence factors.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnostic and therapeutic use of oral micronized progesterone in endocrinology.

Reviews in endocrine & metabolic disorders, 2024

Research

Micronized progesterone and its impact on the endometrium and breast vs. progestogens.

Climacteric : the journal of the International Menopause Society, 2012

Research

Oral micronized progesterone.

Clinical therapeutics, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.